Available to sourceHuman Prescription DrugGastrointestinal

Potassium Chloride in Dextrose and Sodium Chloride (Potassium Chloride, Dextrose Monohydrate and Sodium Chloride)

5 g/100mL / 75 mg/100mL / 450 mg/100mL · Injection Solution

By Baxter Healthcare Company

NDC: 0338-0669
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Salt
Marketing category: NDA

Package sizes

1000 mL in 1 BAG (0338-0669-04)NDC 0338-0669-04Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.